Search

Your search keyword '"Lena, H"' showing total 49 results
Start Over Author "Lena, H" Journal annals of oncology
49 results on '"Lena, H"'

1. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Author

Stahel, R., Hiltbrunner, A., Pardo-Contreras, M., Gasca-Ruchti, A., Giacomelli, N., Kammler, R., Marti, N., Pfister, R., Piguet, A.C., Roux, S., Troesch, S., Schneider, M., Schweri, R., Zigomo, I., Tsourti, Z., Zygoura, P., Tsouprou, S., Kassapian, M., Vervita, K., Dimopoulou, G., Andriakopoulou, C., Morin, F., Amour, E., Mariaule, G., Archirel, N., Fernandez, M., Pereira, E., Benito, L., Lopez, K., Hernández, A., Chinchen, S., Jurkovic, H., Livingstone, A., Mitchell, J., Walker, M., Mitchell, P., Ng, S., Steer, C., Briscoe, K., Saqib, A., Abdi, E., Houghton, B., O’Byrne, K., Chittajallu, B.R., Hughes, B.G., Black, A., Nackaerts, K., Werner, H., Gervais, R., Zalcman, G., Vaylet, F., Merle, P., Monnet, I., Moro-Sibilot, D., Molinier, O., Girard, N., Souquet, P.-J., Barlesi, F., Debieuvre, D., Senellart, H., Poudenx, M., Dixmier, A., Pouessel, D., Cadranel, J., Lena, H., Quoix, E., Friard, S., Audigier-Valette, C., Mazieres, J., Pichon, E., Faehling, M., Kokowski, K., Kirchen, H., Griesinger, F., Tufman, A., De-Colle, C., de Langen, J., González Larriba, J.L., Insa, A., Majem, M., Massutí, B., Pulla, M.P., Aix, S.P., Villanueva, N., Vivanco, G.L., Andrade, J., Curioni-Fontecedro, A., Franks, K., Califano, R., Peters, S., Pujol, J.-L., Dafni, U., Dómine, M., Popat, S., Reck, M., Becker, A., Insa Mollá, A., López Vivanco, G., Madelaine, J., Provencio Pulla, M., Roschitzki-Voser, H., Ruepp, B., Stahel, R.A., Le Pechoux, C., and De Ruysscher, D.

Published
2022
Full Text
View/download PDF

5. Cilengitide combined with cetuximab and platinum-based chemotherapy as first-line treatment in advanced non-small-cell lung cancer (NSCLC) patients: results of an open-label, randomized, controlled phase II study (CERTO)

Author

Vansteenkiste, J., Barlesi, F., Waller, C.F., Bennouna, J., Gridelli, C., Goekkurt, E., Verhoeven, D., Szczesna, A., Feurer, M., Milanowski, J., Germonpre, P., Lena, H., Atanackovic, D., Krzakowski, M., Hicking, C., Straub, J., Picard, M., Schuette, W., and O'Byrne, K.

Published
2015
Full Text
View/download PDF

6. Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

Author

Moran, T., Wei, J., Cobo, M., Qian, X., Domine, M., Zou, Z., Bover, I., Wang, L., Provencio, M., Yu, L., Chaib, I., You, C., Massuti, B., Song, Y., Vergnenegre, A., Lu, H., Lopez-Vivanco, G., Hu, W., Robinet, G., Yan, J., Insa, A., Xu, X., Majem, M., Chen, X., de las Peñas, R., Karachaliou, N., Sala, M.A., Wu, Q., Isla, D., Zhou, Y., Baize, N., Zhang, F., Garde, J., Germonpre, P., Rauh, S., ALHusaini, H., Sanchez-Ronco, M., Drozdowskyj, A., Sanchez, J.J., Camps, C., Liu, B., Rosell, R., Colinet, B., De Grève, J., Germonpré, P., Chen, H., Du, J., Gao, Y., Hu, J., Kong, W., Li, L., Li, R., Li, X., Liu, J., Ren, W., Wen, L., Xiao, X., Yang, J., Yang, M., Yang, Y., Yin, J., Yue, X., Zhang, J., Zhu, L., Bombaron, P., Chouaid, C., Dansin, E., Fournel, P., Fraboulet, G., Gervais, R., Hominal, S., Kahlout, S., Lecaer, H., Lena, H., LeTreut, J., Locher, C., Molinier, O., Monnet, I., Oliviero, G., Schoot, R., Thomas, P., Vergnènegre, A., Berchem, G., Al Husaini, H., Aparisi, F., Arriola, E., Ballesteros, I., Barneto, I., Bernabé, R., Blasco, A., Bosch-Barrera, J., Calvo de Juan, V., Carcereny, E., Catot, S., De las Peñas, R., Dómine, M., Felip, E., García-Campelo, M.R., García-Girón, C., García-Gómez, R., Garcia-Sevila, R., Gasco, A., Gil, J., González-Larriba, J.L., Hernando-Polo, S., Jantus, E., Jiménez, B., Lianes, P., López-López, R., López-Martín, A., López-Vivanco, G., Macias, J.A., Marti-Ciriquian, J.L., Montoyo, R., Morales-Espinosa, D., Morán, T., Moreno, M.A., Pallares, C., Parera, M., Pérez-Carrión, R., Porta, R., Reguart, N., Rosillo, F., Sanchez, J.M., Sullivan, I., Terrasa, J., Trigo, J.M., Valdivia, J., Viñolas, N., Viteri, S., Botia-Castillo, M., Mate, J.L., Perez-Cano, M., Ramirez, J.L., Sanchez-Rodriguez, B., Taron, M., Tierno-Garcia, M., Mijangos, E., Ocaña, J., Pereira, E., Shao, J., Sun, X., and O'Brate, R.

Published
2014
Full Text
View/download PDF

7. 1121P Real-world (RW) data from the sotorasib French pre-market authorization early access program in patients (pts) with KRASG12C driven metastatic non-small cell lung cancer (mNSCLC): Clinical characteristics

Author

Cadranel, J., primary, Quantin, X., additional, Girard, N., additional, Barlesi, F., additional, Auliac, J.B., additional, Couraud, S., additional, Madroszyk Flandin, A-C., additional, Pabst, L., additional, Rieux, C., additional, Curcio, H., additional, Gille, R., additional, Métivier, A-C., additional, Becht, C., additional, Bylicki, O., additional, Tomasini, P., additional, Veillon, R., additional, Damade, C., additional, Mourad, C., additional, Veillard, C., additional, and Lena, H., additional

Published
2022
Full Text
View/download PDF

8. 1173P Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study

Author

Cho, B.C., primary, Ahn, M-J., additional, Kim, T.M., additional, Kim, C., additional, Shim, B.Y., additional, Han, J-Y., additional, Drilon, A.E., additional, Lena, H., additional, Gomez, J.E., additional, Gray, J.E., additional, Awad, M., additional, Perez, J., additional, Navas, M., additional, Kaul, M., additional, Patel, S., additional, Gao, B., additional, Magnan, H., additional, and Rietschel, P., additional

Published
2022
Full Text
View/download PDF

9. LBA10 Sotorasib versus docetaxel for previously treated non-small cell lung cancer with KRAS G12C mutation: CodeBreaK 200 phase III study

Author

Johnson, M.L., primary, de Langen, A.J., additional, Waterhouse, D.M., additional, Mazieres, J., additional, Dingemans, A-M.C., additional, Mountzios, G., additional, Pless, M., additional, Wolf, J., additional, Schuler, M., additional, Lena, H., additional, Skoulidis, F., additional, Okamoto, I., additional, Kim, S-W., additional, Linardou, H., additional, Novello, S., additional, Chen, Y., additional, Solomon, B., additional, Obiozor, C., additional, Wang, Y., additional, and Paz-Ares, L., additional

Published
2022
Full Text
View/download PDF

10. 1050P Association of ctDNA quantification with prognosis and early prediction of response to first-line osimertinib in NSCLC patients

Author

Denis, M.G., primary, Herbreteau, G., additional, Charpentier, S., additional, Vallée, A., additional, Cadranel, J., additional, Audigier Valette, C., additional, Tomasini, P., additional, Masson, P., additional, Pons-Tostivint, E., additional, Gervais, R., additional, Girard, N., additional, Cortot, A., additional, Molinier, O., additional, Monnet, I., additional, Marcq, M., additional, Urban, T., additional, Moro-Sibilot, D., additional, Lena, H., additional, Sagan, C., additional, and Bennouna, J., additional

Published
2022
Full Text
View/download PDF

11. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Author

Della-Fiorentina, S., Begbie, S., Jennens, R., Dass, J., Pittman, K., Ivanova, N., Koynova, T., Petrov, P., Tomova, A., Tzekova, V., Couture, F., Hirsh, V., Burkes, R., Sangha, R., Ambrus, M., Janaskova, T., Musil, J., Novotny, J., Zatloukal, P., Jakesova, J., Klenha, K., Roubec, J., Vanasek, J., Fayette, J., Barlesi, F., Bennouna-Louridi, J., Chouaid, C., Mazières, J., Vallerand, H., Robinet, G., Souquet, P.-J., Spaeth, D., Schott, R., Lena, H., Martinet, Y., El Kouri, C., Baize, N., Scherpereel, A., Molinier, O., Fuchs, F., Josten, K.M., Manegold, C., Marschner, N., Schneller, F., Overbeck, T., Thomas, M., von Pawel, J., Reck, M., Schuette, W., Hagen, V., Schneider, C.-P., Georgoulias, V., Varthalitis, I., Zarogoulidis, K., Syrigos, K., Papandreou, C., Bocskei, C., Csanky, E., Juhasz, E., Losonczy, G., Mark, Z., Molnar, I., Papai-Szekely, Z., Tehenes, S., Vinkler, I., Almel, S., Bakshi, A., Bondarde, S., Maru, A., Pathak, A., Pedapenki, R.M., Prasad, K., Prasad, S.V.S.S., Kilara, N., Gorijavolu, D., Deshmukh, C.D., John, S., Sharma, L.M., Amoroso, D., Bajetta, E., Bidoli, P., Bonetti, A., De Marinis, F., Maio, M., Passalacqua, R., Cascinu, S., Bearz, A., Bitina, M., Brize, A., Purkalne, G., Skrodele, M., Baba, A.A., Ratnavelu, K., Saw, M.H., Samson-Fernando, M.C., Ladrera, G.E., Jassem, J., Koralewski, P., Serwatowski, P., Krzakowski, M., Cebotaru, C., Filip, D., Ganea-Motan, D.E., Ianuli, C.H., Manolescu, I.G., Udrea, A., Burdaeva, O., Byakhov, M., Filippov, A., Lazarev, S., Mosin, I., Orlov, S., Udovitsa, D., Khorinko, A., Protsenko, S., Chang, A., Lim, H.L., Tan, Y.O., Tan, E.H., Bastus Piulats, R., Garcia-Foncillas, J., Valdivia, J., de Castro, J., Domine Gomez, M., Kim, S.W., Lee, J.-S., Kim, H.K., Lee, J.S., Shin, S.W., Kim, D.-W., Kim, Y.-C., Park, K.C., Chang, C.-S., Chang, G.-C., Goan, Y.-G., Su, W.-C., Tsai, C.-M., Kuo, H.-P., Benekli, M., Demir, G., Gokmen, E., Sevinc, A., Crawford, J., Giaccone, G., Haigentz, M., Owonikoko, T., Agarwal, M., Pandit, S., Araujo, R., Vrindavanam, N., Bonomi, P., Berg, A., Wade, J., Bloom, R., Amin, B., Camidge, R., Hill, D., Rarick, M., Flynn, P., Klein, L., Lo Russo, K., Neubauer, M., Richards, P., Ruxer, R., Savin, M., Weckstein, D., Rosenberg, R., Whittaker, T., Richards, D., Berry, W., Ottensmeier, C., Dangoor, A., Steele, N., Summers, Y., Rankin, E., Rowley, K., Giridharan, S., Kristeleit, H., Humber, C., Taylor, P., Ramalingam, S., Perez-Soler, R., Douillard, J.-Y., Thatcher, N., Wang, Y., Pultar, P., Zhu, J., and Malik, R.

Published
2013
Full Text
View/download PDF

16. Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial

Author

Peters, S., primary, Pujol, J.-L., additional, Dafni, U., additional, Dómine, M., additional, Popat, S., additional, Reck, M., additional, Andrade, J., additional, Becker, A., additional, Moro-Sibilot, D., additional, Curioni-Fontecedro, A., additional, Molinier, O., additional, Nackaerts, K., additional, Insa Mollá, A., additional, Gervais, R., additional, López Vivanco, G., additional, Madelaine, J., additional, Mazieres, J., additional, Faehling, M., additional, Griesinger, F., additional, Majem, M., additional, González Larriba, J.L., additional, Provencio Pulla, M., additional, Vervita, K., additional, Roschitzki-Voser, H., additional, Ruepp, B., additional, Mitchell, P., additional, Stahel, R.A., additional, Le Pechoux, C., additional, De Ruysscher, D., additional, Stahel, R., additional, Hiltbrunner, A., additional, Pardo-Contreras, M., additional, Gasca-Ruchti, A., additional, Giacomelli, N., additional, Kammler, R., additional, Marti, N., additional, Pfister, R., additional, Piguet, A.C., additional, Roux, S., additional, Troesch, S., additional, Schneider, M., additional, Schweri, R., additional, Zigomo, I., additional, Tsourti, Z., additional, Zygoura, P., additional, Tsouprou, S., additional, Kassapian, M., additional, Dimopoulou, G., additional, Andriakopoulou, C., additional, Morin, F., additional, Amour, E., additional, Mariaule, G., additional, Archirel, N., additional, Fernandez, M., additional, Pereira, E., additional, Benito, L., additional, Lopez, K., additional, Hernández, A., additional, Chinchen, S., additional, Jurkovic, H., additional, Livingstone, A., additional, Mitchell, J., additional, Walker, M., additional, Ng, S., additional, Steer, C., additional, Briscoe, K., additional, Saqib, A., additional, Abdi, E., additional, Houghton, B., additional, O’Byrne, K., additional, Chittajallu, B.R., additional, Hughes, B.G., additional, Black, A., additional, Werner, H., additional, Zalcman, G., additional, Vaylet, F., additional, Merle, P., additional, Monnet, I., additional, Girard, N., additional, Souquet, P.-J., additional, Barlesi, F., additional, Debieuvre, D., additional, Senellart, H., additional, Poudenx, M., additional, Dixmier, A., additional, Pouessel, D., additional, Cadranel, J., additional, Lena, H., additional, Quoix, E., additional, Friard, S., additional, Audigier-Valette, C., additional, Pichon, E., additional, Kokowski, K., additional, Kirchen, H., additional, Tufman, A., additional, De-Colle, C., additional, de Langen, J., additional, Insa, A., additional, Massutí, B., additional, Pulla, M.P., additional, Aix, S.P., additional, Villanueva, N., additional, Vivanco, G.L., additional, Franks, K., additional, and Califano, R., additional

Published
2022
Full Text
View/download PDF

17. LBA41 Nivolumab (nivo) ± ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC)

Author

Girard, N., primary, Mazieres, J., additional, Otto, J., additional, Lena, H., additional, Lepage, C., additional, Egenod, T., additional, Smith, D., additional, Madelaine, J., additional, Gérinière, L., additional, El Hajbi, F., additional, Ferru, A., additional, Clément-Duchêne, C., additional, Madroszyk, A., additional, Desrame, J., additional, Morin, F., additional, Langlais, A., additional, Michel, P., additional, Louvet, C., additional, Westeel, V., additional, and Walter, T., additional

Published
2021
Full Text
View/download PDF

18. 1404P Clinical characteristics and therapeutics sequences of KRAS G12C metastatic non-small cell lung cancer (mNCSLC) patients treated by sotorasib in the French pre-marketing authorization (MA) early access program (cohort temporary authorization of use, cATU)

Author

Lena, H., Cadranel, J., Girard, N., Mazieres, J., Curcio, H., Gille, R., Madroszyk Flandin, A-C., Auliac, J.B., Bylicki, O., Rieux, C., Couraud, S., Barlesi, F., Pichon, E., Métivier, A-C., Almotlak, H., Pabst, L., Deldycke, C., Duchemann, B., De Gunten, L., and Quantin, X.

Published
2023
Full Text
View/download PDF

21. Real-world treatment patterns, clinical practice and outcomes for locally advanced, non resectable, non-small cell lung cancer from the French ESME Lung database

Author

Girard, N., primary, Pérol, M., additional, Simon, G., additional, Audigier Valette, C., additional, Gervais, R., additional, Debieuvre, D., additional, Schott, R., additional, Quantin, X., additional, Coudert, B., additional, Lena, H., additional, Carton, M., additional, Robain, M., additional, Filleron, T., additional, and Chouaid, C., additional

Published
2019
Full Text
View/download PDF

23. Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1

Author

Robinet, G., Thomas, P., Breton, J.L., Léna, H., Gouva, S., Dabouis, G., Bennouna, J., Souquet, P.J., Balmes, P., Thiberville, L., Fournel, P., Quoix, E., Riou, R., Rebattu, P., Pérol, M., Paillotin, D., and Mornex, F.

Published
2001
Full Text
View/download PDF

24. Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Author

Wislez, M., primary, Blons, H., additional, Domblides, C., additional, Barlesi, F., additional, Mazieres, J., additional, Monnet, I., additional, Kiakouama Maleka, L., additional, Quantin, X., additional, Taillade, L., additional, Lena, H., additional, Fraisse, P., additional, Janicot, H., additional, Audigier Valette, C., additional, Amour, E., additional, Langlais, A., additional, Rabbe, N., additional, Cadranel, J., additional, Laurent puig, P., additional, and Lavolé, A., additional

Published
2018
Full Text
View/download PDF

25. 1306P Platin pemetrexed with or without bevacizumab with upfront versus “at progression” brain radiotherapy in advanced non squamous non-small cell lung cancer with asymptomatic brain metastasis: A randomized phase III trial (Metal2 trial)

Author

Monnet, I., Vergnenegre, A., Robinet, G., Berard, H., Lamy, R., Falchero, L., S. vieillot, Schott, R., Lena, H., Chouabe, S., Thomas, P., Gervais, R., Flandin, A-C. Madroszyk, Abdiche, S., Chiappa, A-M., Greillier, L., Decroisette, C., Auliac, J.B., and Chouaid, C.

Published
2020
Full Text
View/download PDF

26. Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer

Author

Palmero, R., primary, Bidoli, P., additional, Bondarenko, I.M., additional, Boyer, M., additional, Germonpre, P., additional, Ghizdavescu, D., additional, Kotsakis, A., additional, Lena, H., additional, Losonczy, G., additional, Park, K., additional, Reck, M., additional, Su, W.-C., additional, Kallinteris, N., additional, Tang, M., additional, Lai, J., additional, Shan, J., additional, and Spigel, D.R., additional

Published
2017
Full Text
View/download PDF

28. Quality of resection and outcome in stage III thymic epithelial tumors (TET): A retrospective analysis of 150 cases from the national network RYTHMIC experience

Author

Bluthgen, M.V., primary, Dansin, E., additional, Ou, D., additional, Lena, H., additional, Mazieres, J., additional, Pichon, E., additional, Thillays, F., additional, Massard, G., additional, Quantin, X., additional, Oulkhouir, Y., additional, Hon, T. Nguyen Tan, additional, Thiberville, L., additional, Clement-Duchene, C., additional, Lindsay, C., additional, Missy, P., additional, Molina, T., additional, Girard, N., additional, Besse, B., additional, and Thomas, P., additional

Published
2016
Full Text
View/download PDF

29. Efficacy and safety of pasireotide LAR or everolimus alone, or in combination in patients with advanced carcinoids (NET) of the lung/thymus: Results from the randomized, phase 2 LUNA study

Author

Ferolla, P., primary, Brizzi, M.P., additional, Meyer, T., additional, Mansoor, W., additional, Mazieres, J., additional, Cao, C.D., additional, Lena, H., additional, Berruti, A., additional, Damiano, V., additional, Buikhuisen, W., additional, Stankovic, M., additional, Singh, N., additional, Chiodini, E., additional, Gislimberti, G., additional, Oberg, K., additional, and Baudin, E., additional

Published
2016
Full Text
View/download PDF

30. Updated efficacy and safety from the global phase II NP28673 study of alectinib in patients (pts) with previously treated ALK+ non-small-cell lung cancer (NSCLC)

Author

Barlesi, F., primary, Dingemans, A.-M.C., additional, Yang, J.C.-H., additional, Ou, S.-H.I., additional, Ahn, J.S., additional, De Petris, L., additional, Hughes, B., additional, Lena, H., additional, Bordogna, W., additional, Golding, S., additional, Morcos, P.N., additional, Balas, B., additional, Zeaiter, A., additional, and Kim, D.-W., additional

Published
2016
Full Text
View/download PDF

31. 1405P - Circulating tumor DNA (ctDNA) in advanced non-small cell lung cancer (NSCLC) from HIV-infected patients is associated to shorter overall survival (OS): Results from phase II trial (IFCT-1001 CHIVA)

Author

Wislez, M., Blons, H., Domblides, C., Barlesi, F., Mazieres, J., Monnet, I., Kiakouama Maleka, L., Quantin, X., Taillade, L., Lena, H., Fraisse, P., Janicot, H., Audigier Valette, C., Amour, E., Langlais, A., Rabbe, N., Cadranel, J., Laurent puig, P., and Lavolé, A.

Published
2018
Full Text
View/download PDF

34. 1364P - Final clinical results from SUNRISE: A phase III, randomized, double-blind, placebo-controlled multicenter trial of bavituximab plus docetaxel in patients with previously treated stage IIIb/IV nonsquamous non-small cell lung cancer

Author

Palmero, R., Bidoli, P., Bondarenko, I.M., Boyer, M., Germonpre, P., Ghizdavescu, D., Kotsakis, A., Lena, H., Losonczy, G., Park, K., Reck, M., Su, W.-C., Kallinteris, N., Tang, M., Lai, J., Shan, J., and Spigel, D.R.

Published
2017
Full Text
View/download PDF

35. Quality of Life Analysis of Esogia-Gfpc-Gecp Trial- a Phase Iii, Randomized, Multicenter Study Comparing in Elderly Patients (≥70 Years) with Stage Iv Nsclc a Treatment Allocation Based on Ps and Age with an Experimental Strategy According to a Comprehensive Geriatric Assessment (Cga)

Author

Corre, R., primary, Chouaid, C., additional, Greillier, L., additional, Caer, H. Le, additional, Valette, C. Audigier, additional, Baize, N., additional, Berard, H., additional, Falchero, L., additional, Descourt, R., additional, Dansin, E., additional, Vergnenegre, A., additional, Bigay-Gamé, L., additional, Schott, R., additional, Garff, G. Le, additional, Treut, J. Le, additional, Sureda, B. Massuti, additional, Daures, J., additional, Plassot, C., additional, and Lena, H., additional

Published
2014
Full Text
View/download PDF

36. Crizotinib in Patients with Lung Cancer and Ros1 Fusion: Results from the European Cohort Euros1.

Author

Mazières, J., primary, Zalcman, G., additional, Crinò, L., additional, Biondani, P., additional, Filleron, T., additional, Dingemans, A.C., additional, Lena, H., additional, Monnet, I., additional, Rothschild, S.I., additional, Cappuzzo, F., additional, Thiberville, L., additional, Barlesi, F., additional, Dziadziuszko, R., additional, Smit, E.F., additional, Wolf, J., additional, Spirig, C., additional, Pecuchet, N., additional, Diebold, J., additional, Milia, J., additional, and Gautschi, O., additional

Published
2014
Full Text
View/download PDF

37. Cilengitide (Cil) Combined with Cetuximab and Platinum-Based Chemotherapy As First-Line Treatment in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients (Pts): Phase Ii Randomised Certo Study

Author

Vansteenkiste, J.F., primary, Barlesi, F., additional, Waller, C., additional, Bennouna, J., additional, Gridelli, C., additional, Goekkurt, E., additional, Verhoeven, D., additional, Szczesna, A., additional, Feurer, M., additional, Milanowski, J., additional, Germonpre, P., additional, Lena, H., additional, Atanackovic, D., additional, Krzakowski, M., additional, Hicking, C., additional, Straub, J., additional, Picard, M., additional, Schuette, W., additional, and Byrne, K. O', additional

Published
2014
Full Text
View/download PDF

38. Time, a Phase 2B/3 Study Evaluating Tg4010 in Combination with First Line Therapy in Advanced Non Small Cell Lung Cancer (Nsclc). Phase 2B Results

Author

Quoix, E., primary, Losonczy, G., additional, Forget, F., additional, Chouaid, C., additional, Papai, Z., additional, Gervais, R., additional, Ottensmeier, C., additional, Szczesna, A., additional, Kazarnowicz, A., additional, Beck, J.T., additional, Westeel, V., additional, Felip, E., additional, Debieuvre, D., additional, Madroszyk, A., additional, Lacoste, G., additional, Tavernaro, A., additional, Bastien, B., additional, Palanche, T., additional, Limacher, J., additional, and Lena, H., additional

Published
2014
Full Text
View/download PDF

42. Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Author

Ramalingam, S., primary, Crawford, J., additional, Chang, A., additional, Manegold, C., additional, Perez-Soler, R., additional, Douillard, J.-Y., additional, Thatcher, N., additional, Barlesi, F., additional, Owonikoko, T., additional, Wang, Y., additional, Pultar, P., additional, Zhu, J., additional, Malik, R., additional, Giaccone, G., additional, Della-Fiorentina, S., additional, Begbie, S., additional, Jennens, R., additional, Dass, J., additional, Pittman, K., additional, Ivanova, N., additional, Koynova, T., additional, Petrov, P., additional, Tomova, A., additional, Tzekova, V., additional, Couture, F., additional, Hirsh, V., additional, Burkes, R., additional, Sangha, R., additional, Ambrus, M., additional, Janaskova, T., additional, Musil, J., additional, Novotny, J., additional, Zatloukal, P., additional, Jakesova, J., additional, Klenha, K., additional, Roubec, J., additional, Vanasek, J., additional, Fayette, J., additional, Bennouna-Louridi, J., additional, Chouaid, C., additional, Mazières, J., additional, Vallerand, H., additional, Robinet, G., additional, Souquet, P.-J., additional, Spaeth, D., additional, Schott, R., additional, Lena, H., additional, Martinet, Y., additional, El Kouri, C., additional, Baize, N., additional, Scherpereel, A., additional, Molinier, O., additional, Fuchs, F., additional, Josten, K.M., additional, Marschner, N., additional, Schneller, F., additional, Overbeck, T., additional, Thomas, M., additional, von Pawel, J., additional, Reck, M., additional, Schuette, W., additional, Hagen, V., additional, Schneider, C.-P., additional, Georgoulias, V., additional, Varthalitis, I., additional, Zarogoulidis, K., additional, Syrigos, K., additional, Papandreou, C., additional, Bocskei, C., additional, Csanky, E., additional, Juhasz, E., additional, Losonczy, G., additional, Mark, Z., additional, Molnar, I., additional, Papai-Szekely, Z., additional, Tehenes, S., additional, Vinkler, I., additional, Almel, S., additional, Bakshi, A., additional, Bondarde, S., additional, Maru, A., additional, Pathak, A., additional, Pedapenki, R.M., additional, Prasad, K., additional, Prasad, S.V.S.S., additional, Kilara, N., additional, Gorijavolu, D., additional, Deshmukh, C.D., additional, John, S., additional, Sharma, L.M., additional, Amoroso, D., additional, Bajetta, E., additional, Bidoli, P., additional, Bonetti, A., additional, De Marinis, F., additional, Maio, M., additional, Passalacqua, R., additional, Cascinu, S., additional, Bearz, A., additional, Bitina, M., additional, Brize, A., additional, Purkalne, G., additional, Skrodele, M., additional, Baba, A.A., additional, Ratnavelu, K., additional, Saw, M.H., additional, Samson-Fernando, M.C., additional, Ladrera, G.E., additional, Jassem, J., additional, Koralewski, P., additional, Serwatowski, P., additional, Krzakowski, M., additional, Cebotaru, C., additional, Filip, D., additional, Ganea-Motan, D.E., additional, Ianuli, C.H., additional, Manolescu, I.G., additional, Udrea, A., additional, Burdaeva, O., additional, Byakhov, M., additional, Filippov, A., additional, Lazarev, S., additional, Mosin, I., additional, Orlov, S., additional, Udovitsa, D., additional, Khorinko, A., additional, Protsenko, S., additional, Lim, H.L., additional, Tan, Y.O., additional, Tan, E.H., additional, Bastus Piulats, R., additional, Garcia-Foncillas, J., additional, Valdivia, J., additional, de Castro, J., additional, Domine Gomez, M., additional, Kim, S.W., additional, Lee, J.-S., additional, Kim, H.K., additional, Lee, J.S., additional, Shin, S.W., additional, Kim, D.-W., additional, Kim, Y.-C., additional, Park, K.C., additional, Chang, C.-S., additional, Chang, G.-C., additional, Goan, Y.-G., additional, Su, W.-C., additional, Tsai, C.-M., additional, Kuo, H.-P., additional, Benekli, M., additional, Demir, G., additional, Gokmen, E., additional, Sevinc, A., additional, Haigentz, M., additional, Agarwal, M., additional, Pandit, S., additional, Araujo, R., additional, Vrindavanam, N., additional, Bonomi, P., additional, Berg, A., additional, Wade, J., additional, Bloom, R., additional, Amin, B., additional, Camidge, R., additional, Hill, D., additional, Rarick, M., additional, Flynn, P., additional, Klein, L., additional, Lo Russo, K., additional, Neubauer, M., additional, Richards, P., additional, Ruxer, R., additional, Savin, M., additional, Weckstein, D., additional, Rosenberg, R., additional, Whittaker, T., additional, Richards, D., additional, Berry, W., additional, Ottensmeier, C., additional, Dangoor, A., additional, Steele, N., additional, Summers, Y., additional, Rankin, E., additional, Rowley, K., additional, Giridharan, S., additional, Kristeleit, H., additional, Humber, C., additional, and Taylor, P., additional

Published
2013
Full Text
View/download PDF

46. 1246P - Quality of Life Analysis of Esogia-Gfpc-Gecp Trial- a Phase Iii, Randomized, Multicenter Study Comparing in Elderly Patients (≥70 Years) with Stage Iv Nsclc a Treatment Allocation Based on Ps and Age with an Experimental Strategy According to a Comprehensive Geriatric Assessment (Cga)

Author

Corre, R., Chouaid, C., Greillier, L., Caer, H. Le, Valette, C. Audigier, Baize, N., Berard, H., Falchero, L., Descourt, R., Dansin, E., Vergnenegre, A., Bigay-Gamé, L., Schott, R., Garff, G. Le, Treut, J. Le, Sureda, B. Massuti, Daures, J., Plassot, C., and Lena, H.

Published
2014
Full Text
View/download PDF

47. 1235P - Cilengitide (Cil) Combined with Cetuximab and Platinum-Based Chemotherapy As First-Line Treatment in Advanced Non-Small Cell Lung Cancer (Nsclc) Patients (Pts): Phase Ii Randomised Certo Study

Author

Vansteenkiste, J.F., Barlesi, F., Waller, C., Bennouna, J., Gridelli, C., Goekkurt, E., Verhoeven, D., Szczesna, A., Feurer, M., Milanowski, J., Germonpre, P., Lena, H., Atanackovic, D., Krzakowski, M., Hicking, C., Straub, J., Picard, M., Schuette, W., and Byrne, K. O'

Published
2014
Full Text
View/download PDF

49. 721TiP A phase I/II study of davutamig (REGN5093), a MET×MET bispecific antibody, in patients with MET-altered, advanced non-small cell lung cancer (aNSCLC): Trial in progress update.

Author

Ahn, M-J., Cho, B.C., Kim, T.M., Han, J-Y., Kim, C., Shim, B., Drilon, A., Blumenschein, G., Villaruz, L., Gray, J.E., Pujol, J-L., Lena, H., Moro-Sibilot, D., Perez, J., Modi, D.A., Park, J.S., Patel, S., Li, S., Kim, E., and Magnan, H.

Subjects
*NON-small-cell lung carcinoma, *BISPECIFIC antibodies
Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results